Login

Hantz Group employs a holistic approach to provide clients with comprehensive financial, estate, and tax planning solutions. 00:10:00

Share On Facebook Share On Twitter

John Hantz - Chief Executive Officer - Hantz Holdings llc

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
AI Antitrust Regulation: Insights from the UK | Cooley AI | Caroline Hobson - Partner, Cooley LLP
00:10:00
Understanding Stock Market Volatility and Its Impact on Your 401(k) | David Kudla, CEO, Mainstay Capital Management.
00:10:00
Vantea Smart’s Successful Market Debut and Focus on Cybersecurity | Simone Veglioni, CEO , Vantea Smart SPA.
00:10:00
Vijay Chandok, MD & CEO of ICICI Securities, shares market analysis as part of the #DiwaliDialogue series on Instagram.
00:10:00
How to Organize Your Money with the Bucket Approach | Wealth Management with J.P. Morgan
00:10:00
Q1 2022 Market Review: Impact of Geopolitical Events, Inflation, and Investment Strategies
00:10:00
Hafnia CEO Mikael Skov on Product Tankers, Oil Demand, and Investing | Mikael Skov - CEO of Hafnia Ltd
00:10:00
Adapting to Renewable Energy Market Dynamics | Dr. Christoph Husmann, CEO, Encavis AG.
00:10:00
we are focused on the real estate technology industry|Aaron Block,Managing PartnerMetaProp
00:10:00
Exploring the ICT Sector's Growth: Insights from Silverlake's Goh Peng Ooi | Goh Peng Ooi , Founder, Silverlake Axis Ltd.
00:10:00
Martin Vohánka on Eurowag's Role in the 2nd Economic Transformation | Martin Vohánka, CEO, W.A.G. Payment Solutions.
00:00:00
Karen Aiach, CEO, Lysogene

© 2017 - Neuhu+